The study identifies CX43-dependent STAT1 signaling as mediating astrocyte-induced chemoresistance but doesn't reveal the specific downstream effectors or target genes. Understanding these molecular targets is critical for developing combination therapies to overcome brain metastasis chemoresistance. Gap type: unexplained_observation Source paper: Astrocytes Protect Brain Metastatic Breast Cancer Cells From Chemotherapy Through CX43 Dependent STAT1 Signaling in Co-Culture Spheroids. (2026, Biotechnol Bioeng, PMID:41486609)
Landscape Summary: What are the downstream molecular targets of CX43-dependent STAT1 signaling that confer chemoresistance? is a 0.82 priority gap in neuro-oncology. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What are the downstream molecular targets of CX43-dependent STAT1 signaling that confer chemoresistance? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: